產(chǎn)品詳情
簡單介紹：
Anti-ASPH/Aspartate beta hydroxylase抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-ASPH/Aspartate beta hydroxylase抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ASPH/Aspartate beta hydroxylase
Cat. Number:
Anti-ASPH/Aspartate beta hydroxylase抗體KL-12137R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Aspartyl/asparaginyl beta-hydroxylase (ASPH) is a widely-expressed type II membrane protein involved in calcium homeostasis. Located in the endoplasmic reticulum, ASPH specifically hydroxylates an Asp Anti-ASPH/Aspartate beta hydroxylase抗體or Asn residue in the epidermal growth factor-like (EGF) domains of several proteins, using iron as a cofactor. The ASPH gene encodes 3 proteins, ASPH, Junctin, and Junctate (or Humbug), that differ significantly in their C-terminal domains. These ASPH gene products are expressed as five transcript variants that differ by their roles in calcium storage and release, hydroxylation capabilities, and tissue specificity. While all ASPH variants are expressed in skeletal muscle, only some are detected in heart, brain, pancreas, placenta, lung, liver, and kidney tissues. In the lumen of the endoplasmic reticulum, ASPH can be processed into two different forms.
Also known as:
Anti-ASPH/Aspartate beta hydroxylase抗體ASP beta hydroxylase; Aspartyl/asparaginyl beta hydroxylase; ASPH; BAH; CASQ2BP1; HAAH; JCTN; junctin; Peptide aspartate beta dioxygenase; ASPH_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ASPH/Aspartate beta hydroxylase.
●
Predicted Molecular Weight: 86kDa.
Storage:
Shipped at 4℃, Anti-ASPH/Aspartate beta hydroxylase抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Anti-ASPH/Aspartate beta hydroxylase抗體Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Anti-ASPH/Aspartate beta hydroxylase抗體Optimal working dilutions must be determined by the end user.
kl355Mu01 花生四烯酸-5-脂加氧酶(ALOX5)多克隆抗體 Polyclonal Antibody to Arachidonate-5-Lipoxygenase (ALOX5)
kl355Ra01 花生四烯酸-5-脂加氧酶(ALOX5)多克隆抗體 Polyclonal Antibody to Arachidonate-5-Lipoxygenase (ALOX5)
kl357Hu01 細(xì)胞外信號調(diào)節(jié)激酶1(ERK1)多克隆抗體 Polyclonal Antibody to Extracellular Signal Regulated Kinase 1 (ERK1)
kl358Hu01 凋亡信號調(diào)節(jié)激酶I(ASK1)多克隆抗體 Polyclonal Antibody to Apoptosis Signal Regulating Kinase 1 (ASK1)
kl360Hu01 酸性神經(jīng)鞘磷脂酶(ASM)多克隆抗體 Polyclonal Antibody to Acid Sphingomyelinase (ASM)
kl361Hu01 ****擴張性共濟失調(diào)突變因子(ATM)多克隆抗體 Polyclonal Antibody to Ataxia Telangiectasia Mutated (ATM)
kl364Hu01 乳腺癌易感蛋白2(BRCA2)多克隆抗體 Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl364Mu01 乳腺癌易感蛋白2(BRCA2)多克隆抗體 Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
kl365Hu01 葡萄糖激酶調(diào)節(jié)蛋白(GKRP)多克隆抗體 Polyclonal Antibody to Glucokinase Regulatory Protein (GKRP)
kl366Hu01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl366Mu01 血管內(nèi)皮鈣黏蛋白(CDH5)多克隆抗體 Polyclonal Antibody to Cadherin 5 (CDH5)
kl367Hu01 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Mu01 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl367Ra01 血管內(nèi)皮生長因子受體2(VEGFR2)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
kl368Hu01 肝配蛋白A受體1(EPHA1)多克隆抗體 Polyclonal Antibody to Ephrin Type A Receptor 1 (EPHA1)
